NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/05/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,030.75 mln
Float32.06 mln
Earnings Date07/30/2026
EPS
2.06
Solid
P / E
16.20
Moderately valued
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-3.22
Reliable
1-Year Forecast
54.33
Transformational upside
Relative Strength
30
/ 100
Underperforming
Business Description
Collegium Pharmaceutical is a Massachusetts-based company focused on bringing pain management treatments to patients. Its product lineup includes several prescription medicines that address conditions ranging from severe chronic pain and ADHD to opioid-induced constipation. Founded in 2002, the company has built a portfolio of both extended-release and immediate-release formulations designed to give doctors and patients more tailored treatment options.
